Anticoagulants in Long-Term Care

Atrial fibrillation is common among frail elders in long-term care (LTC) and is a significant risk factor for severe stroke. This risk can be reduced with antithrombotic therapy, but the risk of bleeding complications from these treatments may in some cases outweigh their stroke-reduction benefits. In this timely review by William Smucker, MD, catch up on the safety of various antithrombotic agents and how LTC providers can make evidence-based treatment decisions when prescribing these agents.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s